Pacific Biosciences of California
PACB
2.72
+0.02
+0.74%
Pacific Biosciences of California
US · PACB
#3373 by market cap
2.72
+0.02
+0.74%
Live - 5344 symbols - heartbeat 529s ago
· 2026-10-08 09:10
Pre-market
2.65
-2.57%
After-hours
2.70
-0.74%
Overnight
2.72
0.00%
- Market cap
- 845.46M
- P/E (TTM)i
- -6.48
- P/Bi
- -25.42
- EPSi
- -1.82
- Div yieldi
- 0.00%
- 52W posi
- 70%
Reader sentiment
Are you bullish or bearish on PACB?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
- Total institutional ownership fell 2.1 percentage points.
Institutional ownership
- Held by institutions
- 60.78% -2.12pp
- Institutions
- 258 -1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund40.62%
Hedge Fund8.82%
Public Company8.06%
Private Company2.24%
Individual/Insider1.07%
VC/PE Fund0.54%
Insurance Company0.31%
Other38.18%
Top holders as of 2026-06-30
BlackRock
10.40% · 32.34M sh
ARK Investment Management LLC
9.58% · 29.78M sh
SoftBank Group Corp.
6.58% · 20.45M sh
Vanguard Capital Management, LLC
5.01% · 15.59M sh
Geode Capital Management, LLC
2.45% · 7.61M sh
Amova Asset Management
1.93% · 6.01M sh
State Street Global Advisors
1.92% · 5.96M sh
Point72 Asset Management, L.P.
1.54% · 4.79M sh
Two Sigma Investments, LP
1.36% · 4.24M sh
D. E. Shaw & Co., L.P.
1.35% · 4.21M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 38 buys · 12 sells
| Name | Role | Stake |
|---|---|---|
| Christian O. Henry | Chief Executive Officer | 0.40% |
| Mark Van Oene | Chief Operating Officer | 0.33% |
| Kathy Ordonez | Independent Director | 0.13% |
| James Gibson | Chief Financial Officer | 0.05% |
| John Milligan | Independent Chairperson | 0.04% |
| Marshall Mohr | Independent Director | 0.04% |
| Michele Farmer | Vice President | 0.03% |
| William Ericson | Independent Director | 0.01% |
| Hannah Valantine | Independent Director | 0.01% |
| Lucy Shapiro | Independent Director | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-16 | Mark Van Oene | Chief Operating Officer | Open Market Disposition | -26,911 | $1.13 |
| 2026-08-09 | Mark Van Oene | Chief Operating Officer | Other Acquisition | +489,130 | -- |
| 2026-08-09 | Mark Van Oene | Chief Operating Officer | Other Derivative Acquisition | +1,967,888 | $1.15 |
| 2026-06-02 | William Ericson | Independent Director | Other Derivative Acquisition | +223,492 | $1.58 |
| 2026-06-02 | Kathy Ordonez | Independent Director | Other Derivative Acquisition | +223,492 | $1.58 |
| 2026-06-02 | John Milligan | Independent Chairperson | Other Derivative Acquisition | +223,492 | $1.58 |
| 2026-06-02 | Marshall Mohr | Independent Director | Other Derivative Acquisition | +223,492 | $1.58 |
| 2026-06-02 | Christopher Smith | Director | Other Derivative Acquisition | +223,492 | $1.58 |
| 2026-06-02 | Randall Livingston | Independent Director | Other Derivative Acquisition | +223,492 | $1.58 |
| 2026-06-02 | Christopher Gibson | Director | Other Derivative Acquisition | +74,497 | $1.58 |
| 2026-06-02 | Hannah Valantine | Independent Director | Other Derivative Acquisition | +223,492 | $1.58 |
| 2026-04-07 | Christopher Gibson | Director | Other Acquisition | +57,473 | -- |
| 2026-04-07 | Christopher Gibson | Director | Other Derivative Acquisition | +77,842 | $1.52 |
| 2026-03-31 | James Gibson | Chief Financial Officer | Open Market Disposition | -88,185 | $1.37 |
| 2026-03-02 | Christian O. Henry | Chief Executive Officer | Open Market Disposition | -12,497 | $1.51 |
| 2026-03-02 | Christopher Gibson | Director | Other Acquisition | +53,913 | -- |
| 2026-03-02 | Christopher Gibson | Director | Other Derivative Acquisition | +73,087 | $1.52 |
| 2026-03-02 | Mark Van Oene | Chief Operating Officer | Open Market Disposition | -6,504 | $1.51 |
| 2026-03-02 | Michele Farmer | Vice President | Open Market Disposition | -2,979 | $1.51 |
| 2026-02-26 | Christian O. Henry | Chief Executive Officer | Other Acquisition | +920,810 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 09:10:31 · For reference only, not investment advice and not tailored to your situation.